Obstructive Lung Disease Flashcards
What are the risk factors for emphysema/bronchitis (COPD)?
- Cigarette smoking/passive smoke
- industrial exposure (coal, textiles, gold mining, asbestos)
- ambient air pollution
- alpha1-antitrypsin deficiency
- only known genetic abnormality that leads to COPD
- accounts for <1% of cases
What is the definition of COPD?
Chronic bronchitis?
- COPD- A preventable and treatable disease characterized by progressive pulmonary airflow limitations, not fully reversible and an abnormal inflammatory response to noxious gases or particles
- Chronic bronchitis- persistent product cough for at least 3 months out of the year for at least two consecutive years
How is COPD different from Asthma?
The obstruction of COPD is not reversible (or incompletely reversible) by bronchodilators
What is the pathophysiology of COPD?
- Cell death and destruction of the alveoli is caused by impaired lung parenchyma and the toxic actions of inflammatory cells (macrophages and neutrophils)
- this leads to fibrosis and increased mucous production
- Dediorioration in elastic recoil of the lungs and small airway collapse
- Enlarged airspace with decreased diffusion capacity
- leading to hypoxia and hypercarbia
What three things cause airway collapse in a pt with COPD during exhalation?
- Deterioration in the elastic recoil causes early small airway collapse
- Decreased rigidity of bronchiolar walls
- turbulent airflow through narrowed bronchioli lowers the pressure inside the bronchioles, favoring collapse
What are the physical S/S used to diagnose COPD?
- Chronic cough
- bronchitis leading to chronic productive cough
- progressive exercise limitation
- dyspnea/Orthopnea (dyspnea when lying flat)
- sputum discoloration (infection)
- wheezing
What kind of testing is used for diagnosis and severity classification of COPD?
- Spirometry (PFT)
- decreased FEV1/FVC ratio less than 70%
- decreased FEF 25-75% (forced expiratory flow)
- Increased RV and normal to increased FRC and TLC
- CXR
- hyperinflation
- flat diaphragm
- vertical cardiac silhouette
- ABG
- Blue bloaters (chronic bronchitis)
- PaO2 <60 mmHG
- PaCO2 >45
- Pink puffers (emphysema)
- PaO2 usually higher than 60
- PaCO2 normal
- Blue bloaters (chronic bronchitis)
How is COPD staged?
- **All stages have FEV1:FEV ratio <70%
- 0: At risk
- normal spirometry but chronic cough or sputum
- 1: Mild COPD
- FEV1 >80%
- 2: Moderate COPD
- 50% <fev>1 <80%</fev>
- 3: Severe COPD
- 30% < FEV1 <50%
- 4: Very severe COPD
- FEV1 < 30%
What are some differences between an emphysema patient and Bronchitis patient?
- Emphysema
- thin
- anxious
- dyspnea
- accessory muscles
- few secretions
- markedly diminished breath sounds
- CXR- hyperinflation and flattened diaphragm
- Bronchitis
- overweight
- cyanosis, dusky appearance
- cough
- copious secretions
- diminished breath sounds
- CXR- increased bronchovascular markings
How is COPD treated?
What are the goals of treatment?
- Goals to relieve the symptoms and slow progression of the disease
- stop smoking!
- supplemental O2 if PaO2 < 55 or HCT > 55 or developing cor pulmonale
- 2L NC at home
- O2 is most effective therapy for COPD
What would you note on a pre-op history and physical of a pt with COPD?
How could you optimize them for anesthesia?
- History and Physical:
- Exercise intolerance
- chronic cough
- dyspnea
- absent breath sounds or wheezing
- prolonged exhalation
- Pre-op optimization:
- smoking cessation
- bronchodilation
- eliminate infection
What are the problems smoking causes?
- decreased ciliary motility and increases sputum production
- decreases pulmonary immune function
- causes airway reactivity and obstructive disease
- most prevalent risk factor associated with post-op morbidity
- 2-6x risk of developing post-op PNA
- best benefit to surgery is to quit 2 months pre-op
- 24 hour abstinence may decrease carboxyhemoglobin level to normal
- but may increase risk of post-op pulmonary complications- may have increase in sputum production, but still worth having them stop!
- impairs wound healing
What are the changes seen with smoking cessation
- 12-24 hours Carboxyhgb drops to 1%
- 2-6 weeks for improved ciliary function
- normalization of immune system at least 6 weeks
- 8 weeks reduction in post-op pulmonary complications
How can we treat COPD patients to dilate airway and prevent bronchospasm?
- sympathomimetics
- produce cAMP –>bronchodilation
- Ex: albuterol, terbutaline–selective B2 agonists
- PDE inhibitors
- inhibit breakdown of cAMP
- Aminophylin
- Steroids
- decrease mucosal edema
- Ex. inhaled steroids; not used accutely, but can help edema
- Cromolyn
- mast cell stabilization and inhibits histamine release
- **combination therapy improves FEV1, dyspnea, and exacerbations
- These pts should always get flu and PNA shot
What other pre-op treatments should we consider for pts with COPD?
- No smoking after midnight- do decrease COHgb
- antibiotics if evidence of respiratory infection
- O2 for hypoxia and/or evidence of increased pulmonary vascular resistance–do not discontinue for transport
- bronchodilators
- hydration